GMED vs. TFX, IART, PODD, ATEC, BAX, RMD, INSP, PEN, MMSI, and HAE
Should you be buying Globus Medical stock or one of its competitors? The main competitors of Globus Medical include Teleflex (TFX), Integra LifeSciences (IART), Insulet (PODD), Alphatec (ATEC), Baxter International (BAX), ResMed (RMD), Inspire Medical Systems (INSP), Penumbra (PEN), Merit Medical Systems (MMSI), and Haemonetics (HAE). These companies are all part of the "surgical & medical instruments" industry.
Globus Medical (NYSE:GMED) and Teleflex (NYSE:TFX) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, community ranking, risk, institutional ownership and valuation.
95.2% of Globus Medical shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 24.3% of Globus Medical shares are owned by insiders. Comparatively, 1.4% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Globus Medical received 24 more outperform votes than Teleflex when rated by MarketBeat users. Likewise, 67.83% of users gave Globus Medical an outperform vote while only 59.68% of users gave Teleflex an outperform vote.
Globus Medical currently has a consensus price target of $66.33, indicating a potential upside of 31.22%. Teleflex has a consensus price target of $267.50, indicating a potential upside of 29.41%. Given Globus Medical's higher probable upside, research analysts plainly believe Globus Medical is more favorable than Teleflex.
Globus Medical has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500.
Teleflex has higher revenue and earnings than Globus Medical. Teleflex is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.
Teleflex has a net margin of 11.98% compared to Globus Medical's net margin of 7.83%. Teleflex's return on equity of 14.98% beat Globus Medical's return on equity.
In the previous week, Teleflex had 4 more articles in the media than Globus Medical. MarketBeat recorded 7 mentions for Teleflex and 3 mentions for Globus Medical. Globus Medical's average media sentiment score of 1.24 beat Teleflex's score of 1.00 indicating that Globus Medical is being referred to more favorably in the media.
Summary
Teleflex beats Globus Medical on 9 of the 16 factors compared between the two stocks.
Get Globus Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GMED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Globus Medical Competitors List
Related Companies and Tools
